Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data?

Lancet Infect Dis. 2011 Oct;11(10):724-6. doi: 10.1016/S1473-3099(11)70143-8. Epub 2011 May 27.

Authors

Carlos G Grijalva¹, Matthew R Moore, Marie R Griffin

Affiliation

¹ Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. carlos.grijalva@vanderbilt.edu

PMID: 21621465
DOI: 10.1016/S1473-3099(11)70143-8

No abstract available

Publication types

Comment

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Female
Humans
Immunity, Herd*
Male
Pneumococcal Infections / immunology*
Pneumococcal Vaccines / immunology*
Streptococcus pneumoniae / immunology*

Substances

Anti-Bacterial Agents
Pneumococcal Vaccines